help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 22, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0308
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/8/3033    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hannon, T. S.
Right arrow Articles by Arslanian, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hannon, T. S.
Right arrow Articles by Arslanian, S. A.
Related Collections
Right arrow Male Endocrinology
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology

Submitted on February 9, 2007
Accepted on May 14, 2007

Growth Hormone Treatment in Adolescent Males with Idiopathic Short Stature: Changes in Body Composition, Protein, Fat, and Glucose Metabolism

Tamara S. Hannon MD*, Kapriel Danadian MD, Chittiwat Suprasongsin MD, and Silva A. Arslanian MD

Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus & Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213; Oneida Pediatric Group, Oneida NY; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

* To whom correspondence should be addressed. E-mail: tamara.hannon{at}chp.edu.

Context: Cross-sectional observations show an inverse relationship between pubertal increase in GH and insulin sensitivity, suggesting that pubertal insulin resistance may be mediated by GH.

Objective: To longitudinally assess the effects of short-term GH supplementation in adolescent males with non-GH deficient idiopathic short stature (ISS) on body composition, substrate metabolism, and insulin sensitivity. Children with ISS were studied to simulate the pubertal increase in GH secretion.

Participants and Setting: Eight males with ISS (10.8-16.5 y) were recruited from pediatric endocrinology clinics at an academic medical center.

Study Design: Participants were evaluated in the General Clinical Research Center before and after 4 months of GH supplementation (0.3 mg/kg/week). Body composition was assessed with dual energy x-ray absorptiometry. Whole body glucose, protein, and fat turnover were measured using stable isotopes. In vivo insulin action was assessed during a 3-hour hyperinsulinemic (40 mU/m2/min)-euglycemic clamp.

Results: GH supplementation led to: 1) increase in hepatic glucose production and fasting insulin levels, 2) increase in lean body mass and decrease in fat mass, and 3) improvement in cardiovascular lipid risk profile. Plasma IGF-1 levels correlated positively with insulin levels.

Conclusions: Four months of GH supplementation in adolescent males with ISS is associated with significant body composition changes and hepatic insulin resistance.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society